Are you interested in powering the next wave of genetic medicines with ReCode Therapeutics? With our cutting-edge SORT LNP delivery technology, we're creating new pathways in precision genetic medicine. We are looking for collaborators as passionate as we are about transforming patient care through innovative research and applications. Discover more about partnership opportunities below: https://lnkd.in/g_ZZF8wF #GeneticMedicine #PrecisionHealthcare #InnovationPartnerships
ReCode Therapeutics’ Post
More Relevant Posts
-
💚 EAP WEBINAR ALERT 💚 Join us for our next webinar hosted by my dear team member - Karlijn Doorn, PhD, Head of Pharma Partnerships & Customer Success at myTomorrows, and Anke Friedetzky, an experienced Medical Affairs Expert in Cell and Gene Therapies. They will share their expertise in designing and launching successful Expanded Access Programs outside the US. 📅 Date: May 23, 2024 ⏰ Time: 12:00 - 12:45 EST / 18:00 – 18:45 CEST Register through this link --> https://lnkd.in/ePA5MgMz Why should you attend? - and what will you will learn! · Recognize the 3 critical regulatory frameworks essential for EAPs and learn strategies for navigating and complying with these regulations across different jurisdictions. · Develop robust mitigation plans for handling supply chain issues and tackling specific cell and rare disease therapies-related challenges. · Discover tactics for collecting fit-for-purpose RWD in your EAP program through real-world case study examples. · Design a sustainable EAP that aligns with organizational objectives, patient needs, and exit strategies—ensuring a smooth transition post-program. Looking forward to seeing you there! . #ExpandedAccess #ManagedAccess #CompassionateUse #RWD
To view or add a comment, sign in
-
-
NIHR Academic Clinical Fellow - ST4 Doctor in Clinical Pharmacology and Therapeutics at University College London
It was great to lead the first practical session of the 'Genetics in Drug Discovery' course at the MRC Biostatistics Unit University of Cambridge. Today, we covered examples including IL-6 inhibitors and drugs for Alzheimer's disease. https://bit.ly/3uD6ddm #genetics #drugdiscovery #bigdata #clinicalpharmacology #R
To view or add a comment, sign in
-
-
Did you know that less than 10% of rare diseases currently have an approved treatment? 🧬 By leveraging transcriptomic analysis, a more complete picture of disease biology can be established – capturing over an estimated 60% of tested patients with suspected genetic disorders, compared to 40-50% with standard Whole Exome and Genome Sequencing. By integrating such multiomic data into your patient profiling and recruitment workflows, the process and precision of drug discovery, development, and commercialization is being redefined. #Multiomics #Transcriptomics #Pharma #Healthcare #Science #MultiomicRevolution #RareDiseaseDay #RDD #RareIsMany #ShareYourColours #LightUpForRare #JoiningForces #RareDisease
To view or add a comment, sign in
-
-
This week’s Medical Science & Tech Digest highlights more fascinating articles. The first publication is an announcement from the U.S. Food and Drug Administration which recently approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or early symptomatic early juvenile metachromatic leukodystrophy (MLD). https://lnkd.in/epcpJtrT The next publication looks at a common anti-clotting drug called heparin, derived from pig intestines, which risks contaminations and infections. A safer, synthetic version has been developed but it requires scaling up for commercial manufacturing. https://lnkd.in/gFB_EE3s The last publication focuses on an MIT professor who has decoded fundamental aspects of Huntington’s disease and glioblastoma, and now uses computation to better understand amyotrophic lateral sclerosis. https://lnkd.in/eTkxfsTN #manhattanlife #medicalscience #healthtechnology #medicaltechnology
To view or add a comment, sign in
-
-
Every stroke can have a devastating impact on a family. In around a third of people, clopidogrel, one of the main antiplatelet drugs, is not working effectively. Because of natural variation in the CYP2C19 gene, some people process the drug too fast, some too slow, and some cannot process it at all. Genetic testing for CYP2C19 variant status can show clinicians how each individual patient is likely to respond to clopidogrel, so they can make personalised treatment decisions to improve patient safety. The Genedrive CYP2C19 ID Kit received NICE recommendation in recent draft guidance. Learn more: https://lnkd.in/e3UKdNGC #GDR #Stroke #HeartHealth #Cardiology #ThriveAfterStroke #StrokeAwarenessMonth #StrokeAssociation #Pharmacogenetics #Pharmacogenomics #Healthcare
To view or add a comment, sign in
-
-
📢 REGULATORY UPDATE - The FDA webinar on Human Gene Therapy Products Incorporating Human Genome Editing guidance dives into the key points covering product development, CMC, nonclinical, and clinical recommendations. Watch webinar: https://lnkd.in/gPnJYQHt At ERGOMED, we're committed to staying ahead in regulatory affairs. With our expertise and dedication to compliance, we're here to help you navigate the ever-evolving regulatory landscape. #FDA #GeneTherapy #RegulatoryAffairs #Compliance #ErgomedExpertise
To view or add a comment, sign in
-
-
The work Regeneron is doing here is really interesting.... Check out the video we made with them (and with the team at Bioscience Communications) to learn more about the potential for this remarkable work.
Congrats to BioScience Communications and Regeneron on the launch of Regeneron Genetic Medicines. We created a number of the storytelling elements on this page, including the primary video that talks about the potential of genetic medicines. Very cool stuff. Also check out our illustrations representing RGM’s disease focus areas. https://lnkd.in/e3jfiNT7 #healthcarecommunications #biotech #biotechcommunications #bioscience #storytelling
To view or add a comment, sign in
-
💊 Undergraduate Pharmacist ⭐ | Passionate about Elevating Healthcare 🌐| Student member of pharma E-bulletin SKBCOP
"Dive into the basics of Pharmacogenomics with me! 🧬 Exploring how our genes impact drug response. Let's explore the intersection of genetics and pharmacy to optimize patient care. Let's make pharmacy personalized! #Pharmacogenomics #Pharmacy"
To view or add a comment, sign in
-
-
Managing Director at MESLO | Distribution Network Specialist | Biobanking | Water and Life Science Enthusiast | Passionate about Water Quality and Biobanking
Exciting Event Alert: Accelerating Science Forum on Longevity and Compliance in Cell and Gene Therapies! 🧬 Join us for a groundbreaking online forum dedicated to the future of healthcare - exploring the latest advancements in cell and gene therapies. Discover how we're tackling longevity and compliance, pushing the boundaries of science to pave the way for new treatments and therapies that could transform lives. 📅 Don't miss this opportunity to connect with leading experts, gain insights into cutting-edge research, and be part of the conversation shaping the future of medicine. Whether you're a scientist, healthcare professional, or just passionate about the next frontier in healthcare innovation, this event is for you. 💡 Learn from the pioneers driving forward these revolutionary therapies, engage in meaningful discussions, and network with professionals from across the globe - all from the comfort of your home or office. Register now to secure your spot in this not-to-be-missed forum and be at the forefront of accelerating science in cell and gene therapies! #CellTherapy #GeneTherapy #HealthcareInnovation #ScienceForum #Longevity #Compliance #MedicalResearch #OnlineEvent
Save the date! Attend our forum with SelectScience on Feb 27 at 16:00 GMT for a deep dive into the longevity and compliance of cell and gene therapies. We'll cover key topics like safety, efficacy, manufacturing and regulatory hurdles. Whether you're a researcher, healthcare pro, or industry enthusiast, gain insights into the future of medicine. Register here: https://hubs.li/Q02ll5Df0
To view or add a comment, sign in
-
-
Say goodbye to lengthy genetic testing. 👋 Our Aptegra Platform reduces genetic stability testing time by 66% using next-generation sequencing technology. That means clients spend less time waiting for test results and, ultimately, helps new therapies get to patients faster. Crucial for patient safety and regulatory approval, watch how we are speeding up genetic testing.
Complete genetic stability testing faster with Aptegra
To view or add a comment, sign in
REGULATORY PHARMACIST, PUBLIC HEALTH SPECIALIST (M&E).
1moI highly recommend